# RESQ PHARMACEUTICALS INC. — Form D

RESQ PHARMACEUTICALS INC. of HENDERSON, NV, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-23. The offering totals $2.0M, of which $247K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2020-04-23
- Form: D
- Accession: 0001805243-20-000002
- Industry: Pharmaceuticals
- Exemptions: 06c, 04.3
- Total offering: $2.0M
- Amount sold: $247K
- Remaining: $1.8M
- Minimum investment: $50K
- Investors: 2
- Date of first sale: 2020-04-07
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-365676

## Issuer

- Name: RESQ PHARMACEUTICALS INC.
- CIK: 0001805243
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 3535 EXECUTIVE TERMINAL DRIVE, HENDERSON, NV, 89052
- Phone: (701) 541-9222

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Ben T Esque | Executive Officer | Haleiwa, HI |
| John T Hyatt | Promoter | Haleiwa, HI |
| BEN ESQUE | Director | HENDERSON, NV |
| BEN ESQUE | Executive Officer | HENDERSON, NV |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2021-06-29](https://search.stillhousedata.com/formd/0001493152-21-015592) | D | $10.0M | $8.8M |

## More

- [CIK 1805243 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1805243&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001805243-20-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.